Role of epithelial cell fibroblast growth factor receptor substrate 2α in prostate development, regeneration and tumorigenesis

Development

Volumn 135, Issue 4, 2008, Pages 775-784

  Zhang, Yongyou ^a   Zhang, Jue ^a   Lin, Yongshun ^a   Lan, Yongsheng ^a   Lin, Chunhong ^a   Xuan, Jim W ^b   Shen, Michael M ^c   McKeehan, Wallace L ^a   Greenberg, Norman M ^d   Wang, Fen ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c College of Physicians and Surgeons ^*  (United States)

^d Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Adaptor proteins; Growth factors; Mouse models; Prostate cancer; Receptor tyrosine kinases

Indexed keywords

ANDROGEN; FIBROBLAST GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR SUBSTRATE 2ALPHA; MITOGEN ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ALLELE; ANDROGEN RELEASE; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; DRUG INHIBITION; EPITHELIUM CELL; GENE EXPRESSION; HISTOPATHOLOGY; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; MORPHOGENESIS; MOUSE; NONHUMAN; ORGANOGENESIS; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; PROSTATE DEVELOPMENT; PROSTATE EPITHELIUM; PROSTATE TUMOR; PROTEIN EXPRESSION; PROTEIN FUNCTION; STAINING;

ALLELES; ANDROGENS; ANIMALS; CELL PROLIFERATION; ENZYME ACTIVATION; EPITHELIAL CELLS; EPITHELIUM; GENE EXPRESSION REGULATION, DEVELOPMENTAL; MALE; MEMBRANE PROTEINS; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; ORGAN SPECIFICITY; ORGANOGENESIS; PROSTATE; PROSTATIC NEOPLASMS; REGENERATION; SEXUAL MATURATION;

ANIMALIA; MUS;

EID: 40949139200     PISSN: 09501991     EISSN: None     Source Type: Journal    
DOI: 10.1242/dev.009910     Document Type: Article

References (40)

1. Bhatia-Gaur, R., Donjacour, A. A., Sciavolino, P. J., Kim, M., Desai. N., Young, P., Norton, C. R., Gridley, T., Cardiff, R. D., Cunha, G. R. et al. (1999). Roles for Nkx3.1 in prostate development and cancer. Genes Dev. 13, 966-977.
2. Donjacour, A. A. and Cunha, G. R. (1988). The effect of androgen deprivation on branching morphogenesis in the mouse prostate. Dev. Biol. 128, 1-14.
3. Donjacour, A. A., Thomson, A. A. and Cunha, G. R. (2003). FGF-10 plays an essential role in the growth of the fetal prostate. Dev. Biol. 261, 39-54.
4. Economides, K. D. and Capecchi, M. R. (2003). Hoxb13 is required for normal differentiation and secretory function of the ventral prostate. Development 130, 2061-2069.
5. Foster, B. A., Gingrich, J. R., Kwon, E. D., Madias, C. and Greenberg, N. M. (1997). Characterization of prostatic epithelial cell lines derived from transgenic adenocarcinoma of the mouse prostate (TRAMP) model. Cancer Res. 57, 3325-3330.
6. Foster, B. A., Kaplan, P. J. and Greenberg, N. M. (1999). Characterization of the FGF axis and identification of a novel FGFR 1 iiic isoform during prostate cancer progression in the TRAMP model. Prostate Cancer Prostate Dis. 2, 76-82.
7. Giri, D., Ropiquet F. and Ittmann, M. (1999). FGF9 is an autocrine and paracrine prostatic growth factor expressed by prostatic stromal cells. J. Cell. Physiol. 180, 53-60.
8. Gotoh, N., Laks, S., Nakashima, M., Lax, I. and Schlessinger, J. (2004). FRS2 family docking proteins with overlapping roles in activation of MAP kinase have distinct spatial-temporal patterns of expression of their transcripts. FEBS Lett. 564, 14-18.
9. Hadari, Y. R., Gotoh, N., Kouhara, H., Lax, I. and Schlessinger, J. (2001). Critical role for the docking-protein FRS2 alpha in FGF receptor-mediated signal transduction pathways. Proc. Natl. Acad. Sci. USA 98, 8578-8583.
10. Huang, L., Pu, Y., Alam, S., Birch, L. and Prins, G. S. (2005). The role of Fgf10 signaling in branching morphogenesis and gene expression of the rat prostate gland: lobe-specific suppression by neonatal estrogens. Dev. Biol. 278, 396-414.
11. Jin, C., McKeehan, K., Guo, W., Jauma, S., Ittmann, M. M., Foster, B., Greenberg, N. M., McKeehan, W. L. and Wang, F. (2003a). Cooperation between ectopic FGFR1 and depression of FGFR2 in induction of prostatic intraepithelial neoplasia in the mouse prostate. Cancer Res. 63, 8784-8790.
12. Jin, C., McKeehan, K. and Wang, F. (2003b). Transgenic mouse with high Cre recombinase activity in all prostate lobes, seminal vesicle, and ductus deferens. Prostate 57, 160-164.
13. Kapian-Lefko, P. J., Chen, T. M., Ittmann, M. M., Barrios, R. J., Ayala, G. E., Huss, W. J., Maddison, L. A., Foster, B. A. and Greenberg, N. M. (2003). Pathobiology of autochthonous prostate cancer in a pre-clinical transgenic mouse model. Prostate 55, 219-237.
14. Kouhara, H., Hadari, Y. R., Spivak-Kroizman, T., Schilling, J., Bar-Sagi, D., Lax, I. and Schlessinger, J. (1997). A lipid-anchored Grb2-binding protein that links FGF-receptor activation to the Ras/MAPK signaling pathway. Cell 89, 693-702.
15. Kwabi-Addo, B., Ropiquet, F., Giri, D. and Ittmann, M. (2001). Alternative splicing of fibroblast growth factor receptors in human prostate cancer. Prostate 46, 163-172.
16. Lamm, M. L., Podlasek, C. A., Barnett, D. H., Lee, J., Clemens, J. Q., Hebner, C. M. and Bushman, W. (2001). Mesenchymal factor bone morphogenetic protein 4 restricts ductal budding and branching morphogenesis in the developing prostate. Dev. Biol. 232, 301-314.
17. Lin, H. Y., Xu, J., Ischenko, I., Ornitz, D. M., Halegoua, S. and Hayman, M. J. (1998). Identification of the cytoplasmic regions of fibroblast growth factor (FGF) receptor 1 which play important roles in induction of neurite outgrowth in PC 12 cells by FGF-1. Mol. Cell. Biol. 18, 3762-3770.
18. Lin, Y., Liu, G., Zhang, Y., Hu, Y. P., Yu, K., Lin, C., McKeehan, K., Xuan, J. W., Ornitz, D. M., Shen, M. M. et al. (2007a). Fibroblast growth factor receptor 2 tyrosine kinase is required for prostatic morphogenesis and the acquisition of strict androgen dependency for adult tissue homeostasis. Development 134, 723-734.
19. Lin, Y., Zhang, J., Zhang, Y. and Wang, F. (2007b). Generation of an Frs2alpha conditional null allele. Genesis 45, 554-559.
20. Liu, W., Selever, J., Murali, D., Sun, X., Brugger, S. M., Ma, L., Schwartz, R. J., Maxson, R., Furuta, Y. and Martin, J. F. (2005). Threshold-specific requirements for Bmp4 in mandibular development. Dev. Biol. 283, 282-293.
21. Lu, W., Luo, Y., Kan, M. and McKeehan, W. L. (1999). Fibroblast growth factor-10. A second candidate stromal to epithelial cell andromedin in prostate. J. Biol. Chem. 274, 12827-12834.
22. McDougall, K., Kubu, C., Verdi, J. M. and Meakin, S. O. (2001). Developmental expression patterns of the signaling adapters FRS-2 and FRS-3 during early embryogenesis. Mech. Dev. 103, 145-148.
23. McKeehan, W. L., Wang, F. and Kan, M. (1998). The helparan sulfate-fibroblast growth factor family: diversity of structure and function. Prog. Nucleic Acid Res. Mol. Biol. 59, 135-176.
24. Ong, S. H., Goh, K. C., Lim, Y. P., Low, B. C., Klint, P., Claesson-Welsh, L., Cao, X., Tan, Y. H. and Guy, G. R. (1996). Sucl-associated neurotrophic factor target (SNT) protein is a major FGF-stimulated tyrosine phosphorylated 90-kDa protein which binds to the SH2 domain of GRB2, Biochem. Biophys. Res. Commun. 225, 1021-1026.
25. Ong, S. H., Lim, Y. P., Low, B. C. and Guy, G. R. (1997). SHP2 associates directly with tyrosine phosphorylated p90 (SNT) protein in FGF-stimulated cells. Biochem. Biophys. Res. Commun. 238, 261-266.
26. Ong, S. H., Guy, G. R., Hadari, Y. R., Laks, S., Gotoh, N., Schlessinger, J. and Lax, I. (2000). FRS2 proteins recruit intracellular signaling pathways by binding to diverse targets on fibroblast growth factor and nerve growth factor receptors. Mol. Cell. Biol. 20, 979-989.
27. Park, J. H., Walls, J. E., Galvez, J. J., Kim, M., Abate-Shen, C., Shen, M. M. and Cardiff, R. D. (2002). Prostatic intraepithelial neoplasia in genetically engineered mice. Am. J. Pathol. 161, 727-735.
28. Podlasek, C. A., Duboule, D. and Bushman, W. (1997). Male accessory sex organ morphogenesis is altered by loss of function of Hoxd-13. Dev. Dyn. 208, 454-465.
29. Polnaszek, N., Kwabi-Addo, B., Wang, J. and Ittmann, M. (2004). FGF17 is an autocrine prostatic epithelial growth factor and is upregulated in benign prostatic hyperplasia. Prostate 60, 18-24.
30. Powers, C. J., McLeskey, S. W. and Wellstein, A. (2000). Fibroblast growth factors, their receptors and signaling. Endocr. Relat. Cancer 7, 165-197.
31. Pu, Y., Huang, L., Birch, L. and Prins, G. S. (2007). Androgen regulation of prostate morphoregulatory gene expression: Fgf10-dependent and -independent pathways. Endocrinology 148, 1697-1706.
32. Rabin, S. J., Cleghon, V. and Kaplan, D. R. (1993). SNT, a differentiation-specific target of neurotrophic factor-induced tyrosine kinase activity in neurons and PC12 cells. Mol. Cell. Biol. 13, 2203-2213.
33. Ropiquet, F., Giri, D., Lamb, D. J. and Ittmann, M. (1999). FGF7 and FGF2 are increased in benign prostatic hyperplasia and are associated with increased proliferation. J. Urol. 162, 595-599.
34. Soriano, P. (1999). Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat. Genet. 21, 70-71.
35. Sugimura, Y., Cunha, G. R. and Donjacour, A. A. (1986). Morphogenesis of ductal networks in the mouse prostate. Biol. Reprod. 34, 961-971.
36. Thomson, A. A. and Cunha, G. R. (1999). Prostatic growth and development are regulated by FGF10. Development 126, 3693-3701.
37. Wang, F. and McKeehan, W. L. (2003). The fibroblast growth factor (FGF) signaling complex. In Handbook of Cell Signaling. Vol. 1 (ed. R. Bradshaw and E. Dennis), pp. 265-270. New York: Academic/ Elsevier Press.
38. Wang, F., McKeehan, K., Yu, C. and McKeehan, W. L. (2002). Fibroblast growth factor receptor 1 phosphotyrosine 766, molecular target for prevention of progression of prostate tumors to malignancy. Cancer Res. 62, 1898-1903.
39. Xu, H. and Goldfarb, M. (2001). Multiple effector domains within SNT1 coordinate ERK activation and neuronal differentiation of PC12 cells. J. Biol. Chem. 276, 13049-13056.
40. Zhang, Y., McKeehan, K., Lin, Y., Zhang, J. and Wang, F. (2007). FGFR1 tyrosine phosphorylation regulates binding of FRS2alpha but not FRS2beta to the receptor. Mol. Endocrinol. doi: 10.1210/ me.2007-0140.